tiprankstipranks
Trending News
More News >
Biolidics Ltd. (SG:8YY)
SGX:8YY
Singapore Market

Biolidics Ltd. (8YY) Financial Statements

Compare
2 Followers

Biolidics Ltd. Financial Overview

Biolidics Ltd.'s market cap is currently S$74.54M. The company's EPS TTM is S$-0.002; its P/E ratio is -14.38; Biolidics Ltd. is scheduled to report earnings on February 27, 2026, and the estimated EPS forecast is S$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total RevenueS$ 784.00KS$ 277.00KS$ 2.49MS$ 2.31MS$ 9.27M
Gross ProfitS$ 187.00KS$ 146.00KS$ 1.16MS$ 483.00KS$ 3.80M
Operating IncomeS$ -1.70MS$ -996.00KS$ -3.04MS$ -3.31MS$ -4.62M
EBITDAS$ -3.03MS$ -1.16MS$ -8.50MS$ -4.58MS$ -3.52M
Net IncomeS$ -3.43MS$ -2.49MS$ -9.37MS$ -5.98MS$ -4.65M
Balance Sheet
Cash & Short-Term InvestmentsS$ 295.00KS$ 183.00KS$ 5.03MS$ 3.96MS$ 10.67M
Total AssetsS$ 4.67MS$ 682.00KS$ 6.09MS$ 11.42MS$ 18.76M
Total DebtS$ 1.75MS$ 2.02MS$ 3.01MS$ 4.25MS$ 5.28M
Net DebtS$ 1.46MS$ 1.84MS$ -2.02MS$ 289.00KS$ -5.39M
Total LiabilitiesS$ 2.94MS$ 2.67MS$ 7.78MS$ 9.09MS$ 10.48M
Stockholders' EquityS$ 1.73MS$ -1.99MS$ -1.69MS$ 2.33MS$ 8.27M
Cash Flow
Free Cash FlowS$ -2.32MS$ -1.97MS$ -3.16MS$ -5.20MS$ -2.76M
Operating Cash FlowS$ -2.31MS$ -1.97MS$ -3.06MS$ -4.64MS$ -2.43M
Investing Cash FlowS$ -5.00KS$ -2.69MS$ 5.00KS$ -860.00KS$ -539.43K
Financing Cash FlowS$ 2.36MS$ -200.00KS$ 4.18MS$ -1.15MS$ 7.50M
Currency in SGD

Biolidics Ltd. Earnings and Revenue History

Biolidics Ltd. Debt to Assets

Biolidics Ltd. Cash Flow

Biolidics Ltd. Forecast EPS vs Actual EPS